Educational Videos
The Cholangiocarcinoma Foundation has put together several videos to help patients have a better understanding of biomarker testing, gene mutations, and clinical trials. Watch the videos and talk with your healthcare provider to discuss your treatment plan and care.
Biomarker Testing
Biomarker testing is essential for every cancer patient because it reveals details about their cancer. You might also hear it called “genomic testing,” “tumor testing,” or “molecular profiling.” Knowing which biomarkers drive your tumor can help you and your doctor decide the best way to treat your cancer by opening the door to treatment options and clinical trials.
For Cholangiocarcinoma Patients, Biomarkers Matter (English)
For Cancer Patients, Biomarkers Matter (English)
For Healthcare Providers, Biomarkers Matter (English)
Mutations Matter for Cholangiocarcinoma Patients (English)
Mutations Matter for Cancer Patients (English)
For Healthcare Providers Treating Cholangiocarcinoma, Mutations Matter (English)
Understanding Your Biomarker Test Results (English)
Immunotherapy
Immunotherapy helps the body’s immune system fight diseases, particularly cancer. It involves stimulating, enhancing, or suppressing immune responses using targeted therapies like monoclonal antibodies, checkpoint inhibitors, and T-cell therapy. Immunotherapy can improve survival rates, reduce side effects, and help develop personalized treatments. Researchers are working to refine methods and expand the application to other diseases.
Immunotherapy for Cancer Patients
Targeted Therapy
Targeted therapy is a specialized cancer treatment that identifies and attacks specific markers on cancer cells. Targeted therapy can improve outcomes by inhibiting cancer cell growth, division, and spread. Common therapies include monoclonal antibodies, tyrosine kinase inhibitors, and immune checkpoint inhibitors. Personalized treatment plans, guided by genomic testing, can maximize the benefits of this innovative approach to cancer care.
FGFR Inhibitors
FGFR Mutations
IDH Inhibitors for Cholangiocarcinoma
IDH Mutations in Cancer
Targeted Therapy
Understanding Antibody Drug Conjugates (ADC)
Clinical Trials
Clinical trials are research studies performed with people that are aimed at evaluating a medical, surgical, or behavioral intervention. Clinical trials study how safe and helpful tests and treatments are. When found to be safe and helpful, they may become tomorrow’s standard of care. Clinical trials can study many things, such as:
- New drugs not yet approved by the U.S. FDA (Food and Drug Administration)
- New uses of drugs already approved by the FDA
- New ways to give drugs, such as in pill form
- Use of alternative medicines, such as herbs and vitamins
- New tests to find and track disease
- Drugs or procedures that relieve symptoms
Basket Trials
Understanding Your Trial Results
Cancer Clinical Trials: Clinical Trials
Cancer Clinical Trials: Trial Phases
Clinical Trials: Informed Consent
Randomized Control Trials
Cancer Clinical Trials: Placebos
Cancer Clinical Trials: Standard of Care
Cancer Clinical Trials: Biopsies
International Videos
Español
For Cholangiocarcinoma Patients, Biomarkers Matter (Spanish)
Mutations Matter for Cholangiocarcinoma Patients (Spanish)
Mutations Matter for Cancer Patients (Spanish)
Making Sense of Your Biomarker Report (Spanish)
Understanding Your Clinical Trial Results (Spanish)
普通话
For Cholangiocarcinoma Patients, Biomarkers Matter (Mandarin)
Mutations Matter for Cholangiocarcinoma Patients (Mandarin)
Mutations Matter for Cancer Patients (Mandarin)
Making Sense of Your Biomarker Report (Mandarin)
Understanding Your Clinical Trial Results (Mandarin)
한국어
Mutations Matter for Cancer Patients (Korean)
Mutations Matter for Cholangiocarcinoma Patients (Korean)
日本語
Mutations Matter for Cancer Patients (Japanese)
Mutations Matter for Cholangiocarcinoma Patients (Japanese)
日本語
Mutations Matter for Cholangiocarcinoma Patients (Thai)
Mutations Matter for Cancer Patients (Thai)
Share These Videos
Biomarkers Matter for Cancer Patients (English)
Mutations Matter for Cholangiocarcinoma Patients (Thai)
Mutations Matter for Cancer Patients (English)
Mutations Matter for Cancer Patients (Spanish)
Mutations Matter for Cancer Patients (Japanese)
Mutations Matter for Cancer Patients (Korean)
Mutations Matter for Cancer Patients (Mandarin)
Basket Trials
Understanding Your Clinical Trial Results
Immunotherapy for Cancer Patients
Targeted Therapy
The Cholangiocarcinoma Foundation is eager to share these videos with other cancer organizations.
Our excitement stems from our firm belief in the significance of biomarker testing and the need for accessible resources for patients and their families. By collaborating with other cancer organizations, we aim to expand the reach of these informative videos, ensuring that individuals across diverse communities can benefit from their valuable insights.
We are committed to raising awareness, disseminating knowledge, and providing support to those affected by cholangiocarcinoma and other forms of cancer.
Together, we can empower patients and healthcare professionals, enabling them to better comprehend and utilize biomarker test reports, ultimately improving outcomes and enhancing the quality of care.